Dr. Nancy Stempin

Dr. Nancy Stempin is currently the Controller for Biopharmaceuticals in the U.S. and Global Consumer Business Units at Pfizer, a position they have held since 2000, with a brief hiatus between 2005 and 2015. Previously, they served as the Global Business Unit Controller at DuPont from 2013 to 2015 and as a Director of Accounting Policy at Novartis from 2005 to 2012. Earlier in their career, Dr. Stempin was a Manager at PricewaterhouseCoopers from 1995 to 2000 and held the role of Director at AICPA from 2012 to 2013. They earned an MBA in Accounting from Drexel University's LeBow College of Business and a Doctorate in Business Administration with a concentration in Accounting from Georgia State University's J. Mack Robinson College of Business.